Share this article and save a life!
50% of men over 50 suffer in silence with BPH.
AI just changed the game.
Griffin Health in Connecticut just launched something remarkable: AI-guided robotic surgery that uses water jets to treat enlarged prostates.
No more choosing between:
• Daily medications with sexual side effects
• Major surgery with long recovery
• Living with constant bathroom trips
The numbers are staggering:
🔹 50-70% of men over 50 have BPH symptoms
🔹 Most rely on medications causing dizziness, low blood pressure, sexual dysfunction
🔹 Traditional surgery (TURP) risks incontinence and sexual problems
Here’s what makes this breakthrough different:
The AquaBeam system uses real-time ultrasound and AI to create a personalized treatment map. Then a robotic waterjet precisely removes excess prostate tissue in minutes.
The result?
✅ Preserves sexual function
✅ Maintains continence
✅ Faster recovery than traditional surgery
✅ Works for all prostate sizes
✅ 5-year data shows durable outcomes
Dr. Johnson Tsui at Griffin calls it “person-centered” care. I call it overdue.
Think about it:
We use AI to recommend movies and predict traffic patterns, but millions of men have been stuck choosing between bad side effects or worse quality of life.
This isn’t just about technology. It’s about dignity.
Men shouldn’t have to plan their days around bathroom locations or sacrifice intimacy for basic urinary function.
The broader implication?
AI-guided precision surgery is moving from experimental to mainstream. If we can revolutionize something as common as BPH treatment, imagine what’s next for conditions affecting millions.
The future of surgery isn’t just robotic, it’s intelligent, personalized, and preserves what matters most to patients.
♻️ Repost if men’s health deserves precision medicine too.
👉 Follow me, Jonathan Govette, for daily, real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/
